-transparent.png){kind=logo}
The high serum concentration of estrone sulfate and the presence of estrone sulfatase in breast tumors constitute an important mechanism of local synthesis of estrogens in the tissue. Thus, inhibitors of estrone sulfatase may be effective in the treatment of estrogen-dependent breast cancer. In this study, we synthesized several isostructural analogs of estrone sulfate (estrone-3-methylsulfonate, estrone phosphate, 3-desoxyestradiol-3-methylenesulfonate, and 3-desoxyestrone-3-methylenesulfonate) and tested them on human placental sterylsulfatase. The results were (i) The Ki of 3-desoxyestrone-3-methylenesulfonate 12 and 3-desoxyestradiol-3-methylenesulfonate 7 are more than 100-fold higher than the Ki or KM values for estrone sulfate, (ii) As compared to estrone sulfate, the Ki value for estrone-3-methylsulfonate 2 is about 30-fold higher, while estrone phosphate 3 is bound by the sulfatase with roughly the same affinity as estrone sulfate. The results shed some light on the electronical and sterical requirements for high affinity binding to the enzyme.
P K Li, and
R Pillai, and
L Dibbelt
April 1997,
Steroids,
P K Li, and
R Pillai, and
L Dibbelt
December 2002,
Biochemistry,
P K Li, and
R Pillai, and
L Dibbelt
July 2009,
Anti-cancer agents in medicinal chemistry,
P K Li, and
R Pillai, and
L Dibbelt
January 2003,
Steroids,
P K Li, and
R Pillai, and
L Dibbelt
January 1994,
Journal of medicinal chemistry,
P K Li, and
R Pillai, and
L Dibbelt
September 1996,
The Journal of steroid biochemistry and molecular biology,
P K Li, and
R Pillai, and
L Dibbelt
March 2015,
Drug development research,
P K Li, and
R Pillai, and
L Dibbelt
October 2003,
Cancer research,
P K Li, and
R Pillai, and
L Dibbelt
January 1998,
Steroids,
P K Li, and
R Pillai, and
L Dibbelt
May 2002,
Bioorganic & medicinal chemistry letters,
